Summit Therapeutics (SMMT) EPS (Diluted) Growth (1y) (2018 - 2024)
Summit Therapeutics (SMMT) EPS (Diluted) Growth (1y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 17,091.12% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Summit Therapeutics | 10.39 Bn | 9.70 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -60.62% |
| Sep 30, 2024 | -149.53% |
| Jun 30, 2024 | -220.58% |
| Mar 31, 2024 | 95.50% |
| Dec 31, 2023 | 39.83% |
| Sep 30, 2023 | 71.73% |
| Jun 30, 2023 | 79.36% |
| Mar 31, 2023 | -528.86% |
| Dec 31, 2022 | 64.26% |
| Sep 30, 2022 | 40.99% |
| Jun 30, 2022 | 50.28% |
| Mar 31, 2022 | -8.43% |
| Dec 31, 2021 | -50.84% |
| Sep 30, 2021 | 23.79% |
| Jun 30, 2021 | -18.52% |
| Mar 31, 2021 | -124.28% |
| Dec 31, 2020 | 86.35% |
| Sep 30, 2020 | -32.86% |
| Mar 31, 2020 | 58.43% |
| Oct 31, 2019 | 57.84% |